Stock 002399 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Equities

002399

CNE100000P02

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
10.12 CNY -0.59% Intraday chart for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. -3.89% -13.73%
Apr. 29 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Change of Financial Controller from Mr. Xiang Xianqing to Ms. Chen Juan
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Directorate Changes
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Board Changes
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Executive Changes
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Change of Joint Company Secretary
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Resignation of Sun Xuan as the Vice Chairman and the Executive Director
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Resignation of Bu Haihua as the Non-Executive Director
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Joint Company Secretary of the Company and an Authorized Representative Changes
CI
Shenzhen Hepalink Pharmaceutical Co., Ltd. Elects Independent Director and Supervisors
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Appoints Frank Sun as Executive Director and Vice Chairman of the Board
CI
Shenzhen Hepalink Pharmaceutical Co.,Ltd. has Changed its Name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd
CI
Shenzhen Hepalink Pharmaceutical Co., Ltd. Elects Zhang Rongqing as Independent Director; Approves Profit Distribution Plan for the Year 2013
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002399 Stock
  4. News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW